ENTITY
SMARTSCORE: 3/5
Abbvie Inc

Abbvie Inc (ABBV US)

170
Analysis
Health CareUnited States
AbbVie Inc. researches and develops pharmaceutical products. The Company produces pharmaceutical drugs for specialty therapeutic areas such as immunology, chronic kidney disease, Hepatitis C, women's health, oncology, and neuroscience. AbbVie also offers treatments for diseases including Multiple Sclerosis, Parkinson's, and Alzheimer's disease.
more
11 Sep 2022 15:51

Incannex Healthcare (IHL AU): Attractive Idea Backed by Niche Focus on Cannabinoid Pharmaceuticals

Incannex has 28+ drug candidates for broad range of under-met medical conditions representing major economic opportunities. The company is well...

Logo
438 Views
Share
bullishAbbvie Inc
01 Sep 2022 12:53

AbbVie Inc: Agreement With Cugene & Other Developments

AbbVie has witnessed a strong correction over the past few months and its results have also not been the best. The company’s revenues in the last...

Logo
239 Views
Share
bullishPfizer Inc
21 Jul 2022 10:29

Pfizer Inc (PFE US): What’s Lie Ahead of Comirnaty? Potential Blockbuster Drugs in Pipeline

By leveraging on windfall gains from COVID portfolio, Pfizer is developing additional growth spots for future revenue growth. Its pipeline and...

Logo
424 Views
Share
bearishS&P 500 INDEX
12 Jul 2022 22:33

U.S. Indexes Form Bear Flag Patterns Within Downtrends; Opportunities Within Health Care

We continue to view the price action over the past month as a bear market bounce in the S&P 500, Nasdaq 100 (QQQ), and Russell 2000 (IWM), as each...

Logo
446 Views
Share
12 Jul 2022 15:15

Data Mining Technical Publications to Rank the Innovators in RNA Therapeutics

Specialists lead the RNA intellectual property ecosystem but may still need big pharma  to bring new treatments to market making the space ripe for...

Logo
422 Views
Share
x